EXCLUSIVE: Telo Genomics' Smoldering Multiple Myeloma Prognostic Test Predicts Risk Of Disease Progression, Study Shows
Telo Genomics Announces Agreement for Strategic Advisory Services
Telo Genomics to Raise $2M Through Private Placement of Units
Telo Genomics Appoints Kris Weinberg as CEO
No Data